Anti-CD20 Antibody Therapy for Sjogren's Syndrome

Clinical trial NCT00101829 · COMPLETED

Trial details

NCT number: NCT00101829
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2004-04-01
Primary completion: 2006-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.